by Rakovina Therapeutics | Jul 15, 2025 | Uncategorized
DOWNLOAD Vancouver, British Columbia, July 15, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery,...
by Rakovina Therapeutics | Jul 11, 2025 | Uncategorized
DOWNLOAD Award Recognition underscores the importance of Al-driven drug discovery Vancouver, British Columbia, July 11, 2025 — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation...
by Rakovina Therapeutics | Jul 10, 2025 | Uncategorized
DOWNLOAD Vancouver, British Columbia, July 10, 2025 — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered...
by Rakovina Therapeutics | Jul 1, 2025 | Uncategorized
Download Vancouver, British Columbia, June 30, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery,...
by Rakovina Therapeutics | Jul 1, 2025 | Uncategorized
Download Vancouver, British Columbia, June 30, 2025 – Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”) announces that it will apply to the TSX Venture Exchange (the “Exchange”) to amend the terms of certain outstanding warrants and convertible...